Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| Also, we improved focus and efficiency in our company and are committed to continue optimizing our organization to streamline and propel growth |
| We are training a lot of users and administrators, and of course, we are going live in the sequence that I described and beginning to measure impact, which we are confident will be very encouraging going forward |
| We have a growing list of expansions and new client wins under our belt, and we are confident our selling motion resonates across the healthcare landscape |
| I'm proud to say that in Q4, provider and patient satisfaction measured by our [indiscernible] operating metric reached all-time highs |
| We are quite confident that this will continue through the process going forward |
| We are very excited to be in the growth phase of our company and really humbled by the opportunity to help wonderful people, including our women and men in uniform, and many other people that deserve better care than they get today |
| In 2024, we will continue to enable the digital aspiration of healthcare organizations with long-term profitable growth well within our sights |
| So, we are so pleased that most of our clients are on Converge and it's going to only get better from here |
| We begin the year in a position of strong visibility into our future growth and our path to profitability |
| We know they are really, really happy |
| And of course, that includes the very large, very sophisticated clients where we have enormous advantage over others |
| The high 90s, it's very, very impressive |
| We believe we do not need to spend more on SG&A to achieve our growth goals and there is healthy operating leverage as we scale |
| There is growing understanding of the challenges and sophistication required for such a platform, and the fact that we have so many clients migrated to Converge with very clear proof point is definitely a very strong tailwind for us in both segments, both for providers and payers |
| With our healthy balance sheet and improved financial visibility, we have high conviction in our path to profitability |
| I believe we are better positioned than ever to deliver the profitable growth promised by our large market opportunity and highly differentiated SaaS-based software infrastructure platforms |
| And then doing -- yeah, so I think that's really, I think, where you'll see the upside associated with the current base is we expect to be able to see increase at same store sales and expanding with those customers over time |
| And so, the revenue potential from them is much enhanced relative to them remaining on the legacy platform |
| So, we are now in a just different reality than we were even 12 months ago where we are very optimistic on retaining and growing our Converge clientele |
| We are very quickly reaching a point with all the go-lives that we have where we are becoming a very proven infrastructure that is scaling very, very well with very good proof points and metrics and a very safe choice in the market |
| We believe we have made the right moves to return to growth by expanding our footprint within our installed base and winning new clients |
| We have had an excellent reception to our solution, sizable market wins, powerful client validation and we documented compelling proof points |
| It's working really well and it's 100% about execution, efficient execution to generate the positive growth, which also means laser-focused on software subscription, high margin part of our business more than anything else |
| As I mentioned earlier, the results we see with people that have migrated are really excellent in way of -- almost any metric that you would choose |
| We continue to make good progress migrating our clients to Converge |
| In addition to our technology platform, our professional services teams are proving to be a powerful differentiating element for us |
| Last year's early and severe flu season did not repeat this year, so the relatively strong visit volume reflects growth within some of our strategic payer clients |
| Our payer clients leverage our AMG providers to deliver high-quality care for members and also increasingly virtual primary care that improves access and reduces costs |
| In conclusion, we are encouraged by the strides we've made in our business |
| What it does do, it puts us in a fantastic position to upsell those customers now that they're on Converge |
| Statement |
|---|
| Turning to profitability, our fourth quarter gross profit margin was 34%, flat to last quarter, and down from 42% last year |
| AMG visit revenue trended 8% lower than last year and was $32.1 million for the quarter |
| This brings the quarter and the year to down approximately 27% and 19%, respectively, compared to last year after adjusting for software capitalization |
| Subscription revenue declined slightly from Q3 and was $27.3 million in the fourth quarter |
| Hey, Ido, I was listening to the prepared remarks, and I think Bob said subscription revenues were down just modestly from Q3 |
| We saw year-over-year high 20%s decline in '23 versus '22 |
| This was largely due to lower subscription software revenue combined with a revenue mix shift away from higher-margin implementation services to lower-margin marketing services |
| AMG visits were 10% lower this quarter versus a year ago, reflecting the early and severe flu season in 2022, and a return to a more normal onset of flu season in 2023 |
| Approximately $3 million of the decline in revenue versus last year was subscription related, driven primarily by legacy platform declines with the balance split between lower visit and services and care points revenue |
| It's pretty clear that we're guiding negative $35 million, negative $45 million on EBITDA, so that goes to $0 million-plus in the following year |
| As a merit-based organization, our incentive compensation in 2023 reflected our revenue attainment, which was below plan |
| I would expect that, that would have continued in the area of down 30% in '24 |
| The re-platforming-related headwinds from prior periods will impact 2024 subscription revenue, which we expect to decline approximately 10% in the first quarter, then build back up with contracted go-lives |
| In conclusion, while our 2023 financials reflect the headwinds associated with our re-platforming, we believe we are coming out the other side |
| That's not to say that we are not optimistic |
| To begin, total visits were approximately 1.65 million in the fourth quarter, a small decline versus 1.7 million last year |
| If you segment that, it would have been down 30% |
| SG&A declined approximately 8% in Q4 and 18% overall in the second half of 2023 compared to the first half of the year |
| But I think it's fair to say that it's lower than $400 million, given the change in mix that we're anticipating |
| Overall, declines are going to be more like mid-teens |
Please consider a small donation if you think this website provides you with relevant information